- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Agfa strikes DR deal with Canon Medical
Agfa strikes DR deal with Canon MedicalAgfa Medical Systems passed up the opportunity to add digital radiography to its product line when it bought Sterling Diagnostics last year but let Sterling’s subsidiary, Direct Radiography Corp., go
Agfa strikes DR deal with Canon Medical
Agfa Medical Systems passed up the opportunity to add digital radiography to its product line when it bought Sterling Diagnostics last year but let Sterlings subsidiary, Direct Radiography Corp., go (
PNN
2/99). Now the Belgium-based manufacturer of analog film, PACS, and CR will add Canons DR-Thorax system to its family of products. The open-ended agreement, which enables Agfa to market the DR-Thorax system in every country except Japan, will last at least three years and could be the beginning of a broader marketing and distribution relationship between the two companies.
In related news, Agfa signed an agreement with ALI Technologies of Vancouver, BC, whereby ALI will offer Agfa CR and hard-copy image systems with ALIs UltraPACS.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
